npv

In finance, everything comes down to promises. When you invest money, questions arise: how profitable will it be down the line, and is it worth investing today? Determining the exact amount of those returns and whether investing is worthwhile can be challenging.

This lecture will introduce the concept of Net Present Value. It will discuss how NPV helps managers satisfy shareholders without direct interaction, and how it can evaluate uncertain future payoffs in order to meet investor expectations.

A lecture by Raghavendra Rau recorded on 2 October 2023 at Barnard's Inn Hall, London

The transcript and downloadable versions of the lecture are available from the Gresham College website: https://www.gresham.ac.uk/watch-now/net-present-value

Gresham College has offered free public lectures for over 400 years, thanks to the generosity of our supporters. There are currently over 2,500 lectures free to access. We believe that everyone should have the opportunity to learn from some of the greatest minds. To support Gresham's mission, please consider making a donation: https://gresham.ac.uk/support/

Website:  https://gresham.ac.uk
Twitter:  https://twitter.com/greshamcollege
Facebook: https://facebook.com/greshamcollege
Instagram: https://instagram.com/greshamcollege

Je zou het door de coronacrisis bijna vergeten, maar op 1 juli 2020 is de nieuwe donorwet een feit. Kort gezegd komt het hierop neer, dat je automatisch donor bent als je geen keuze maakt. Hoe staan we daar als christenen in? En hoe ga je hier als ouders mee om in de opvoeding van je kinderen, ook als ze zelf voor de keuze komen te staan?

Ik praat erover met Rineke Heij, beleidsadviseur Advies en Toerusting bij de Nederlandse Patiënten Vereniging. Welkom bij deze 22ste aflevering van Bij ons thuis.

Hier vind je de keuzehulp van de NPV: https://npvzorg.nl/keuzehulp-orgaandonatie/

Presentatie: Evert Barten

Gast: Rineke Heij, beleidsadviseur Advies en Toerusting bij de Nederlandse Patiënten Vereniging.

Productie en montage: NLS Music

Bij ons thuis is een wekelijkse podcast van het Reformatorisch Dagblad over christelijke opvoeding.

Kijk ook op http://www.rd.nl/bijonsthuis

A lot of the infrastructure assets relevant to our daily lives, such as roads, bridges, and parks, are provided by city or municipal governments. In this episode, we ask the question: how should we assess the economic viability of city infrastructure projects? To answer this question, we’ve invited Craig Lawrence, Managing Director of Lytton Advisory, back on to the program. Lytton Advisory is an Australian professional services firm specialising in infrastructure economics and decision making.*

Use these (approximate) timestamps to jump right to the highlights:

• 1:00 – conversation starts with host Gene Tunny asking Craig about a recent post (A $7 Crossing) he wrote about the economic viability of Brisbane City Council’s proposed $190 million Kangaroo Point to Brisbane City pedestrian bridge
• 12:00 – discussion of external benefits (or externalities) and wider economic benefits relevant in assessment of city infrastructure projects
• 18:00 – discussion of agglomeration effects and benefits of active transport
• 23:30 – Craig delivers his assessment of the economic viability of the Brisbane City to Kangaroo Point pedestrian bridge – “at the moment, there's not enough evidence on the benefit side, to be able to justify the project “
• 26:00 – further discussion of wider economic benefits – Craig notes a rule of thumb is that they should only be 15-20% on top of private benefits
• 32:00 – Gene commences conversation with Craig about Brisbane City Council’s un-costed redevelopment of Victoria Park Golf Course into a public park and how one might assess its economic viability
• 43:20 – beginning of discussion on Cross River Rail, a controversial new subway system in Brisbane which was originally costed at $5 billion but may end up costing $12 billion, a mega project which Craig has previously been sceptical about (Cross River Rail Dice Roll?) 

*Economics Explained host Gene Tunny is currently working with Craig as a Senior Associate with Lytton Advisory on projects in the Middle East and Australia. 

Combined testing of high-sensitivity cardiac troponin T (hs-cTnT) and copeptin at presentation provides a very high—although still imperfect—negative predictive value (NPV) for the early rule-out of acute myocardial infarction (AMI). We hypothesized that a second copeptin measurement at 1 h might further increase the NPV.